By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Lexicon Pharmaceuticals, Inc. 

8800 Technology Forest Place

The Woodlands  Texas  77381-1160  U.S.A.
Phone: 281-863-3000 Fax: 281-863-8088


SEARCH JOBS


Industry
Pharmaceutical






Company News
Lexicon Pharmaceuticals, Inc. (LXRX) Announces One For Seven Reverse Stock Split Effective May 20, 2015 4/30/2015 6:41:08 AM
Lexicon Pharmaceuticals, Inc. (LXRX) Provides Clinical Pipeline Update And Reports 2015 First Quarter Financial Results 4/30/2015 6:34:38 AM
Lexicon Pharmaceuticals, Inc. (LXRX) To Report First Quarter 2015 Financial Results On April 29, 2015 4/28/2015 10:30:11 AM
Lexicon Pharmaceuticals, Inc. (LXRX) And Bristol-Myers Squibb (BMY) Select Development Candidate For Neuropathic Pain In Neuroscience Drug Discovery And Development Alliance 4/15/2015 2:46:16 PM
Lexicon Pharmaceuticals, Inc. (LXRX) To Present At Needham & Company's 14th Annual Healthcare Conference 4/9/2015 8:00:27 AM
Lexicon Pharmaceuticals, Inc. (LXRX) To Ring The Nasdaq Stock Market Closing Bell 4/8/2015 7:26:42 AM
Lexicon Pharmaceuticals, Inc. (LXRX) Announces First Patient Screened In Pivotal Phase 3 Clinical Trial Of Sotagliflozin 3/25/2015 6:18:54 AM
Lexicon Pharmaceuticals, Inc. (LXRX) And Ipsen (IPN.PA) Expand Their Licensing And Commercialization Agreement For Telotristat Etiprate To Include Canada 3/18/2015 6:50:52 AM
Lexicon Pharmaceuticals, Inc. (LXRX) Completes Enrollment In Pivotal Phase 3 Clinical Trial Of Telotristat Etiprate 3/9/2015 6:34:08 AM
Lexicon Pharmaceuticals, Inc. (LXRX) Provides Clinical Pipeline Update And Reports 2014 Fourth Quarter And Full Year Financial Results 3/4/2015 6:51:08 AM
12345678910...
//-->